Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present United Health Products, Inc. (OTC: UEEC).

Full DD Report for UEEC

You must become a subscriber to view this report.


Recent News from (OTC: UEEC)

United Health Products to Hold Conference Call on December 20, 2018 to Discuss Recent Corporate Developments and Provide Year End Update
HENDERSON, Nev., Dec. 17, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), a manufacturer and marketer of HemoStyp ® , a patented hemostatic gauze for the healthcare and wound care sectors, today announced tha...
Source: GlobeNewswire
Date: December, 17 2018 13:37
United Health Products Retains Legal Counsel Ruskin Moscou Faltischek P.C to Assist in Strategic Review
HENDERSON, Nev., Nov. 02, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp ® , a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it ha...
Source: GlobeNewswire
Date: November, 02 2018 09:00
United Health Products Engages Société Générale to Undertake Strategic Review
HENDERSON, Nev., Oct. 25, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp ® , a patented hemostatic gauze for the healthcare and wound care sectors, today announced the follow...
Source: GlobeNewswire
Date: October, 25 2018 08:30
United Health Products' HemoStyp® to Begin Human Trials
HENDERSON, Nev., Aug. 08, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC: UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that its protocol submission for human testing has been revie...
Source: GlobeNewswire
Date: August, 08 2018 06:00
United Health Products to Offer Retail Sales of HemoStyp® Products on Walmart.com and Jet.com
HENDERSON, Nev., July 09, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it has been accepted as a Walmart.com and  Jet.com supp...
Source: GlobeNewswire
Date: July, 09 2018 09:00
United Health Products Files IDE Pre-Submission with the FDA for Approval to Begin Human Trials of HemoStyp®
HENDERSON, Nev., June 19, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that after successfully completing a series of animal tests, i...
Source: GlobeNewswire
Date: June, 19 2018 09:00
United Health Products Expands Animal Testing for HemoStyp® in Support of PMA Application, Human Trials to Follow
HENDERSON, Nev., May 01, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it is launching expanded and more robust animal testing fo...
Source: GlobeNewswire
Date: May, 01 2018 09:00
United Health Products Forms Medical Advisory Board
HENDERSON, Nev., March 19, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, is pleased to announce the formation of a Medical Advisory Board. ...
Source: GlobeNewswire
Date: March, 19 2018 08:30
United Health Products Receives CE Mark Approval for HemoStyp®
Henderson, Nev., March 13, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC: UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it has obtained Class III and CE mark approval for Hemo...
Source: GlobeNewswire
Date: March, 13 2018 05:30
United Health Products Announces Completion of FDA PMA for HemoStyp®
HENDERSON, Nev., Feb. 05, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC) today announced that, following its January 17 face-to- face meeting with FDA experts and officials, it has  completed and submitted all materials relevant for the premarket approval (PMA) ...
Source: GlobeNewswire
Date: February, 05 2018 09:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-180.620.570.6250.5741,925
2018-12-170.5710.600.610.57175,145
2018-12-140.5740.590.5950.55867,070
2018-12-130.590.590.590.58258,532
2018-12-120.590.58250.590.562519,467

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1817,27541,92541.2045Short
2018-12-1726,17575,14534.8327Cover
2018-12-1412,00067,07017.8918Cover
2018-12-131,8308,53221.4487Cover
2018-12-123,90019,46720.0339Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on UEEC.


About United Health Products, Inc. (OTC: UEEC)

Logo for United Health Products, Inc. (OTC: UEEC)

United Health Products Inc. UEEC develops, manufactures, and markets patented hemostatic gauze, for the dental, healthcare, veterinary and wound care sectors. The product, HemoStyp R , is derived from regenerated oxidized cellulose, which is all natural, designed to absorb exudate/drainage from superficial wounds and helps control bleeding.

 

 

 

Current Management

  • Douglas Beplate / CEO
  • Nate Knight / CFO
  • Steven Morse / Securities Counsel
  • Douglas Beplate /
  • Robert Denser /
  • Nate Knight /

Current Share Structure

  • Market Cap: $160,316,310 - 03/16/2018
  • Authorized: 300,000,000 - 09/30/2016
  • Issue and Outstanding: 161,935,667 - 11/13/2017
  • Float: 99,945,675 - 05/17/2016

 


Recent Filings from (OTC: UEEC)

Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: May, 16 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 17 2018
Annual statement of changes in beneficial ownership of securities
Filing Type: 5Filing Source: edgar
Filing Date: April, 17 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 02 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: March, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 05 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2017

 

 


Daily Technical Chart for (OTC: UEEC)

Daily Technical Chart for (OTC: UEEC)


Stay tuned for daily updates and more on (OTC: UEEC)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: UEEC)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in UEEC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of UEEC and does not buy, sell, or trade any shares of UEEC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/